In what is being heralded as the “most significant expansion of federal law in intellectual property since the Lanham Act in 1946,” Congress this week passed the Defend Trade Secrets Act of 2016 (the “Act”), which had near unanimous support in both the Senate and House of Representatives. The Act provides a uniform set of standards governing trade secret infringement, including a federal claim for trade secret misappropriation, a powerful ex-parte seizure provision, and availability of monetary damages and injunctive relief. Once President Obama signs the Act – which the White House has previously voiced support for – it will go into effect immediately.
Posted: April 28th, 2016 under Trade Secret.
Greater Philadelphia, PA | April 2016 – The Federal Circuit Bar Association will host its anticipated conference, Global Series: Innovation and Trade, on May 13, 2016 at the United States Chamber of Commerce in Washington, D.C. The program will feature multiple topics, including: Trade Agreements, The Trans-Pacific Partnership (TPP), Intellectual Property, and the New World of International Trade.
Posted: April 12th, 2016 under Press Release.
Jeffrey B. Bove, Former Managing Partner and Chair of the IP Litigation Section of Connolly Bove, Joins RatnerPrestia in Wilmington, DE
Wilmington, DE | March 21, 2016 – RatnerPrestia is pleased to announce that Jeffrey B. Bove, former Managing Partner and Chair of the Intellectual Property Litigation Section of Connolly Bove Lodge & Hutz LLP, has joined the firm and will be based in the firm’s Wilmington, Delaware office. Mr. Bove has decades of experience in patent litigation in the District of Delaware and elsewhere, and has also handled numerous complex commercial litigations. He successfully worked on high profile cases such as the Lipitor® patent cases for Pfizer, Bayer v. Housey for Bayer Corp., and Dawson v. Rohm and Haas Company at the United States Supreme Court. He also currently serves on the Board of Governors of the Federal Circuit Bar Association.
Read more »
Posted: March 21st, 2016 under Press Release.
Valley Forge, PA | March 2016 – RP CEO & President, Jonathan H. Spadt, will moderate an expert panel at the Intellectual Property Owners Association’s – Patent Bar & Office Dialogue Summit. The event brings together experts from the United States Patent and Trademark Office (USPTO) and stakeholders to discuss current developments. Panelists will discuss issues related to subject matter eligibility, patent quality, PTAB/IPR and written description. It is scheduled for March 15, 2016 at the JW Marriott Hotel in Washington, D.C.
Posted: March 14th, 2016 under Press Release.
Written by: Sunjeev S. Sikand
This article first appeared in the January 25, 2016 edition of IP Law360
A January 4, 2016 article in IP Law360 raised several issues regarding the USPTO’s handling of the December 2015 power outage, including the USPTO’s statutory authority to declare the power outage days as federal holidays and vulnerabilities of patents having bar dates on a power outage day but filed on the next succeeding business day. Patentees can breathe a sigh of relief in at least one respect – future attacks on “power outage patents,” i.e., patents based on applications with a bar date on a USPTO power outage day, but filed on the first business day after the USPTO electronic filing system came back online, are highly unlikely. In the 2008 Aristocrat decision, the Federal Circuit reiterated that “[p]rocedural lapses during examination, should they occur, do not provide grounds of invalidity.” Still, clarification of the USPTO’s statutory basis to declare the power outage patents as timely filed is needed to protect against several potential pitfalls.
Read more »
Posted: February 3rd, 2016 under Patent.
This article first appeared in the February 3, 2015 edition of the Legal Intelligencer
Inter partes review (IPR) is a powerful alternative or supplement to patent litigation that permits a party to challenge a patent’s validity before the Patent Trial and Appeal Board (PTAB). In fact, the concurrent use of IPR in connection with federal district court patent litigation has become so pervasive that many patent infringement litigants now consider IPRs to be a de facto counterpart to such litigation. From the accused infringer’s perspective, an IPR is an essential consideration and may be an integral part of a defense strategy. In that regard, a patentee must take into account how an IPR could derail its enforcement efforts.
Read more »
Valley Forge, PA | January 4, 2016 – RatnerPrestia is pleased to announce that its Munich, Germany office is now open. RP CEO, Jonathan H. Spadt, notes, “RP now has the ability to represent clients in the U.S., German and European Patent Offices, and seamlessly coordinate multi-jurisdictional litigation, invalidation proceedings, licensing and strategic planning in those same jurisdictions, with one team of expert lawyers all cooperating under one roof.”
Posted: January 2nd, 2016 under Press Release.
Washington, D.C. | December 2015 – RP Shareholder Brian P. O’Shaughnessy, who also serves as Regional Vice President, USA, of the Licensing Executives Society (USA & Canada), secured unanimous approval of three Board resolutions acknowledging and praising the work of the LES Public Policy Committee, and its Chair, Rachel Kreppel, Purdue Pharma. The resolutions were passed at the regular LES board meeting at the Society’s Annual Meeting in New York City, in October.
Posted: December 20th, 2015 under Press Release.
Washington, D.C. | December 2015 – The Life Sciences Summit is being held December 1-2, 2015 in New York City. Brian P. O’Shaughnessy, RatnerPrestia Shareholder and Public Policy & Regional Vice President, Licensing Executives Society (LES) will lead the presentation – “Contracts Are Forever: Positioning Your Assets”. The panel will cover how to position your asset in a contract as well as the road-bumps and land-mines that have tripped up other companies that you need to be aware of.
The Life Sciences Summit is an early-stage investor and business development conference for emerging companies and academic innovators. The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, and medical research foundations with the goal of advancing new innovations into clinical development.
For more information about the event, click here.
Posted: December 2nd, 2015 under Press Release.
Sunjeev Sikand Co-Authors IPO’s Comments on USPTO’s July 2015 Update to Section 101 Eligibility Guidance
Washington, D.C. | November 2015 – Sunjeev Sikand has co-authored a 29-page letter and report to the U.S. Patent and Trademark Office (USPTO) on behalf of the Intellectual Property Owners Association (IPO) in response to a request for public comments on the July 2015 Update to the Patent Subject Matter Eligibility Guidance. IPO said that the interpretation of the patent eligibility case law in the guidance diverged from the narrow holdings of the cases and the views of many commentators and stakeholders, which could lead examiners to reject unnecessarily applications that should be patent eligible. The letter also argued that the USPTO should consider evidence of non-preemption during its initial determination of patent eligibility and should make a detailed showing to support patent ineligibility rejections.
Posted: November 17th, 2015 under Press Release.